MONTREAL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities based in Québec spanning over 1,600,000 sq. ft., is pleased to announce that it has received conditional approval to uplist (the “Uplisting”) its common shares (the “Common Shares”) to the Toronto Stock Exchange (the “TSX”) from the TSX Venture Exchan ...